Chilmark Research July 23, 2019
Precision medicine (PM) is of growing importance in healthcare and was the focus of a major push by the Obama Administration through the Precision Medicine Initiative (PMI) launched in 2015. Chilmark uses Ferryman and Pitcain’s definition of precision medicine as the “effort to collect, integrate, and analyze multiple sources of genetic and non-genetic data and applying data analytics and machine learning/AI to develop insights about health and disease that are tailored to an individual.” With the growth in both biological knowledge and the ability to collect behavioral, social determinants and environmental data, the ability to customize therapies and care pathways in growing dramatically.
Metabolomics, proteomics, microbiomics and beyond are offering substantially more biological data and insights on unique trajectories of...
Today's Sponsors
Today's Sponsor